Neoplasia maligna primária ou metastática que afeta o cólon ou o reto. Exemplos representativos incluem carcinoma, linfoma e sarcoma.
Introdução
O que você precisa saber de cara
O câncer colorretal é um tumor maligno que se desenvolve no cólon ou no reto, comumente chamado de câncer de intestino. Entre os sinais mais comuns percebidos pela pessoa ou pela família estão sangramentos nas fezes, episódios de fraqueza prolongada e alterações nos hábitos de evacuação. Alterações em genes reguladores, como o EPCAM e o TP53, estão documentadas na origem e no desenvolvimento da condição. No sistema público brasileiro, o PET-CT foi incorporado para casos selecionados com metástase no fígado, mas medicamentos biológicos como cetuximabe e bevacizumabe foram recusados pela CONITEC para a primeira linha metastática.
Neoplasia maligna primária ou metastática que afeta o cólon ou o reto. Exemplos representativos incluem carcinoma, linfoma e sarcoma.
Tem tratamento?
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 47 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 117 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
45 genes identificados com associação a esta condição.
Diarrhea 5, with tufting enteropathy, congenital
An intractable diarrhea of infancy characterized by villous atrophy and absence of inflammation, with intestinal epithelial cell dysplasia manifesting as focal epithelial tufts in the duodenum and jejunum.
Leukemia, acute myelogenous
A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.
Colorectal cancer 12
A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. CRCS12 is characterized by a high-penetrance predisposition to the development of colorectal adenomas and carcinomas, with a variable tendency to develop multiple and large tumors. Onset is usually before age 40 years. The histologic features of the tumors are unremarkable.
Colorectal cancer 10
A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.
Tumor predisposition syndrome 4
A disorder characterized by an increased risk for developing various types of benign and/or malignant neoplasms that arise at an accelerated rate and in different organs.
Retinitis pigmentosa 35
A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
Juvenile polyposis syndrome
Autosomal dominant gastrointestinal hamartomatous polyposis syndrome in which patients are at risk for developing gastrointestinal cancers. The lesions are typified by a smooth histological appearance, predominant stroma, cystic spaces and lack of a smooth muscle core. Multiple juvenile polyps usually occur in a number of Mendelian disorders. Sometimes, these polyps occur without associated features as in JPS; here, polyps tend to occur in the large bowel and are associated with an increased risk of colon and other gastrointestinal cancers.
Breast cancer
A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.
Familial adenomatous polyposis 2
A condition characterized by the development of multiple colorectal adenomatous polyps, benign neoplasms derived from glandular epithelium. Some affected individuals may develop colorectal carcinoma.
Ataxia telangiectasia
A rare recessive disorder characterized by progressive cerebellar ataxia, dilation of the blood vessels in the conjunctiva and eyeballs, immunodeficiency, growth retardation and sexual immaturity. Patients have a strong predisposition to cancer; about 30% of patients develop tumors, particularly lymphomas and leukemias. Cells from affected individuals are highly sensitive to damage by ionizing radiation and resistant to inhibition of DNA synthesis following irradiation.
Microcephaly 30, primary, autosomal recessive
A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH30 is characterized by small head, poor overall growth, and global developmental delay with variably impaired intellectual development. Affected individuals may also have variable congenital anomalies, including atrial septal defect, dysmorphic facial features, tracheal stenosis, and anomalies of the skin and teeth.
Thrombocytopenia 10
A form of thrombocytopenia, a hematologic disorder defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. THC10 is an autosomal recessive form characterized by decreased numbers of platelets apparent from birth or early childhood.
Birt-Hogg-Dube syndrome 1
A form of Birt-Hogg-Dube syndrome, a rare genodermatosis usually manifesting in adulthood and characterized by multiple fibrofolliculomas, trichodiscomas, and acrochordons. Patients with this syndrome have an increased susceptibility to develop renal cell carcinoma, lung cysts, and spontaneous pneumothorax. Inheritance is autosomal dominant.
Familial adenomatous polyposis 1
An autosomal dominant cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years.
Hereditary non-polyposis colorectal cancer 6
An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Colorectal cancer
A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.
Breast cancer
A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.
Hereditary non-polyposis colorectal cancer 7
An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Achondroplasia
A frequent form of short-limb dwarfism. It is characterized by a long, narrow trunk, short extremities, particularly in the proximal (rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. ACH is an autosomal dominant disease.
Colorectal cancer
A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.
Colorectal cancer
A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.
Leukemia, juvenile myelomonocytic
An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages.
Mirror movements 1
A disorder characterized by contralateral involuntary movements that mirror voluntary ones. While mirror movements are occasionally found in young children, persistence beyond the age of 10 is abnormal. Mirror movements occur more commonly in the upper extremities. Some MRMV1 patients have agenesis of the corpus callosum.
Lynch syndrome 2
A form of Lynch syndrome, an autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. Lynch syndrome is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, it is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical Lynch syndrome is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected Lynch syndrome' or 'incomplete Lynch syndrome' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Lynch syndrome 1
A form of Lynch syndrome, an autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. Lynch syndrome is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, it is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical Lynch syndrome is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected Lynch syndrome' or 'incomplete Lynch syndrome' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Lynch syndrome 5
A form of Lynch syndrome, an autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. Lynch syndrome is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, it is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical Lynch syndrome is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected Lynch syndrome' or 'incomplete Lynch syndrome' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Lynch syndrome 4
A form of Lynch syndrome, an autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. Lynch syndrome is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, it is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical Lynch syndrome is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected Lynch syndrome' or 'incomplete Lynch syndrome' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Medicamentos e terapias
Mecanismo: Vascular endothelial growth factor A inhibitor
Mecanismo: Vascular endothelial growth factor A inhibitor
Mecanismo: Thymidine phosphorylase inhibitor
Mecanismo: Epidermal growth factor receptor erbB1 inhibitor
Mecanismo: Epidermal growth factor receptor erbB1 inhibitor
Mecanismo: Receptor protein-tyrosine kinase erbB-2 inhibitor
Mecanismo: Fibroblast growth factor receptor 1 inhibitor
Mecanismo: Vascular endothelial growth factor receptor inhibitor
Mecanismo: Thymidylate synthase inhibitor
Variantes genéticas (ClinVar)
265 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
373 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Câncer colorretal
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Com ensaio aberto em 54 países. O ponto verde marca onde há vaga agora.
🟢 Recrutando agora
100 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
Publicações mais relevantes
Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) for preventing colorectal cancer and colorectal adenoma in the general population.
Esta revisão sistemática conclui que os benefícios da aspirina na prevenção primária do câncer colorretal (CRC) são incertos e demorados, com pouca ou nenhuma diferença observada nos primeiros 15 anos de uso, e quaisquer potenciais benefícios a longo prazo (após 15 anos) têm evidência muito incerta. No entanto, a aspirina aumenta comprovadamente o risco de hemorragia extracraniana grave e de acidente vascular cerebral hemorrágico. Assim, a decisão de usar aspirina para a prevenção de CRC deve ser individualizada e feita em conjunto com o médico, equilibrando cuidadosamente o risco de sangramento do paciente com seus potenciais benefícios cardiovasculares.
🇧🇷 traduzidoMulticentre prospective non-interventional study protocol for evaluating surgical strategies for Colorectal Resections and Postoperative Quality of Life in Retroperitoneal Sarcoma Patients Across German-Speaking Sarcoma Centres (COLOSARC-Q).
O estudo COLOSARC-Q investiga as estratégias cirúrgicas para ressecções colorretais em pacientes com sarcomas retroperitoneais (RPS), uma vez que estas cirurgias complexas frequentemente causam complicações e as abordagens ideais ainda são pouco definidas. O principal objetivo é avaliar as técnicas de ressecção e reconstrução intestinal e sua influência na qualidade de vida e no curso da doença pós-operatório. Para médicos e pacientes, os resultados podem otimizar as estratégias cirúrgicas, reduzir complicações como fístulas e obstruções, e melhorar significativamente a recuperação e a qualidade de vida a longo prazo.
🇧🇷 traduzidoGlobal burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
O estudo Global Burden of Disease (GBD) 2023 analisou 292 causas de morte, revelando que doenças cardíacas e AVC permanecem líderes globais, apesar do aumento da expectativa de vida média geral e da redução em doenças preveníveis por vacina. Para pacientes e médicos, é crucial notar as grandes disparidades regionais na mortalidade e a importância de doenças crônicas como o câncer colorretal (não raro na Europa) e outras doenças não transmissíveis, que frequentemente causam mortes prematuras, especialmente em certas regiões. Isso enfatiza a necessidade de intervenções direcionadas e sistemas de saúde resilientes para melhorar a equidade e reduzir mortes evitáveis globalmente.
🇧🇷 traduzidoDendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors.
Este estudo inicial com DEP-SN38 para tumores avançados, incluindo o colorretal, demonstrou que o tratamento foi **clinicamente bem tolerado**, com **poucos efeitos gastrointestinais severos** e **ausência de sintomas colinérgicos**, sendo a neutropenia o principal evento adverso grave. Além disso, foram observados **sinais preliminares de atividade antitumoral** em pacientes fortemente pré-tratados, particularmente no **câncer colorretal**, onde alguns pacientes experimentaram **benefícios duradouros**, inclusive por mais de 12 meses, sugerindo seu potencial clínico.
🇧🇷 traduzidoIdentification of a novel PRUNE2::NTRK2 gene fusion in soft tissue sarcoma patients-friend or foe? Case series.
Este estudo identificou uma nova fusão genética, PRUNE2::NTRK2, em dois pacientes com sarcomas de partes moles (STS), tumores onde tais fusões são cruciais para diagnóstico e tratamento. No entanto, diferentemente de outras fusões NTRK que respondem a terapias direcionadas (como larotrectinib e entrectinib), esta fusão atípica produz uma proteína não funcional. Portanto, seu real impacto para os pacientes – se é um "aliado" ou um "inimigo" para o desenvolvimento da doença e o potencial de tratamento – permanece incerto e requer mais investigação para guiar decisões médicas.
🇧🇷 traduzidoPublicações recentes
iGABASnFR2 is an improved genetically encoded protein sensor of GABA.
Drivers and barriers to influenza vaccination in the post-COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with physicians.
Association of radiomic features of skeletal muscle on CT images with muscle function and physical performance in older men.
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.
Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions: A Systematic Review and Meta-Analysis.
📚 EuropePMCmostrando 65
Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) for preventing colorectal cancer and colorectal adenoma in the general population.
The Cochrane database of systematic reviewsMulticentre prospective non-interventional study protocol for evaluating surgical strategies for Colorectal Resections and Postoperative Quality of Life in Retroperitoneal Sarcoma Patients Across German-Speaking Sarcoma Centres (COLOSARC-Q).
BMJ openIdentification of a novel PRUNE2::NTRK2 gene fusion in soft tissue sarcoma patients-friend or foe? Case series.
Therapeutic advances in medical oncologyGlobal burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Lancet (London, England)Consider the unexpected! An overlooked, elusive, rare but dramatic diagnosis: anorectal melanoma.
Updates in surgeryDendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors.
Journal of clinical oncology : official journal of the American Society of Clinical OncologyThe potential of CT colonography for colorectal cancer screening in Japan.
Japanese journal of radiologyReal-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma.
Molecular diagnosis & therapyOutcomes of loop ileostomy after rectal resection for cancer: A prospective observational multicenter snapshot study from Multidisciplinary Italian Study group for STOmas (MISSTO).
Techniques in coloproctologyPatients' and Clinicians' Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative Study.
Journal of medical Internet researchMeasuring healthy life expectancy and determinants of poor perceived health: A population-based study among a subset of rare and common cancer survivors.
Cancer epidemiologyThe impact of a multidisciplinary team approach on the management of patients diagnosed with complex colorectal polyps.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and IrelandThe genomic landscape of 2,023 colorectal cancers.
NaturePrecision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei.
Clinical cancer research : an official journal of the American Association for Cancer ResearchNeurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
Acta oncologica (Stockholm, Sweden)Increased risk of gastric cancer in relation with pernicious anaemia in patients with primary antibody deficiency: A nationwide case control study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the LiverRecommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Annals of oncology : official journal of the European Society for Medical Oncology[Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
Epidemiologia e prevenzioneUpdated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.
The British journal of surgeryTargeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.
Journal of experimental & clinical cancer research : CR[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Epidemiologia e prevenzioneMeat Intake, Cooking Methods, Doneness Preferences and Risk of Gastric Adenocarcinoma in the MCC-Spain Study.
NutrientsOverall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.
The Lancet regional health. EuropeIs laparoscopic major hepatectomy feasible and safe in Swiss cantonal hospitals?
Swiss medical weeklyIncidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program.
Diseases of the colon and rectumPredicting outcomes in anal cancer patients using multi-centre data and distributed learning - A proof-of-concept study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and OncologyIdentification of known and novel familial cancer genes in Swedish colorectal cancer families.
International journal of cancerDefinition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the LiverMorbidity, risk of cancer and mortality in 3645 HFE mutations carriers.
Liver international : official journal of the International Association for the Study of the LiverA systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors.
Therapeutic advances in medical oncologyClinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationAssociations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncAno-uro-genital mucosal melanoma UK national guidelines.
European journal of cancer (Oxford, England : 1990)Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion.
Clinical colorectal cancerAssociation of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
JAMA network openPrevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics.
Familial cancerCzech and Slovak Diamond-Blackfan Anemia (DBA) Registry update: Clinical data and novel causative genetic lesions.
Blood cells, molecules & diseasesGenetic epidemiology of colorectal cancer and associated cancers.
MutagenesisFamilial aggregation of early-onset cancers.
International journal of cancerFecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
Scandinavian journal of gastroenterologyIdentification of Lynch syndrome risk variants in the Romanian population.
Journal of cellular and molecular medicineAppendiceal neoplasm risk associated with complicated acute appendicitis-a population based study.
International journal of colorectal diseaseMalignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.
Alimentary pharmacology & therapeuticsRecurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population.
PloS oneRevealing the glioma cancer stem cell interactome, one niche at a time.
The Journal of pathologyIs whole-colon investigation by colonoscopy, computerised tomography colonography or barium enema necessary for all patients with colorectal cancer symptoms, and for which patients would flexible sigmoidoscopy suffice? A retrospective cohort study.
Health technology assessment (Winchester, England)A novel APC promoter 1B deletion shows a founder effect in Italian patients with classical familial adenomatous polyposis phenotype.
Genes, chromosomes & cancer[Two cases of the rare Cronkhite-Canada syndrome].
Ugeskrift for laegerComplication Rates in Colonoscopy Screening for Cancer.
Deutsches Arzteblatt internationalRisk of other Cancers in Families with Melanoma: Novel Familial Links.
Scientific reportsCancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
The American journal of gastroenterologyRare disruptive mutations and their contribution to the heritable risk of colorectal cancer.
Nature communicationsEpidermal Growth Factor Receptor Activating Mutations in Squamous Histology of Lung Cancer Patients of Southern Bulgaria.
Folia medicaThe Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
European journal of human genetics : EJHGCancer among circumpolar populations: an emerging public health concern.
International journal of circumpolar healthAssociation of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight.
International journal of immunogeneticsThree Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.
The Journal of molecular diagnostics : JMDThe experience of a referral centre and literature overview of GIST and carcinoid tumours in inflammatory bowel diseases.
International journal of surgery (London, England)Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes.
Pediatric blood & cancerThe Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.
The Journal of clinical endocrinology and metabolismThe EUROMED CANCER network: state-of-art of cancer screening programmes in non-EU Mediterranean countries.
European journal of public healthTrends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)Systematic search for rare variants in Finnish early-onset colorectal cancer patients.
Cancer geneticsHuman papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.
Journal of clinical oncology : official journal of the American Society of Clinical OncologyGlioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome.
European journal of neurologyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Câncer colorretal.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Câncer colorretal e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
É uma neoplasia maligna primária ou metastática que acomete o cólon ou o reto. Inclui formas histológicas como carcinoma, sarcoma e linfoma, sendo popularmente chamado de câncer de intestino.
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
10 publicações do grafo RarasNet (PubMed) · 5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Câncer colorretal. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/cancer-colorretal
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
Câncer colorretal
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- Genética mendeliana
- fonte: OMIM
- Moléculas estudadas na doença
- fonte: OpenTargets
- Reposicionamento
- fonte: Drug Repurposing Hub
- Ensaios clínicos
- fonte: ClinicalTrials.gov
